Ana Tari Ashizawa

Dr. Ana Tari Ashizawa is a scientific co-founder of Bio-Path Holdings and serves as Senior Vice President of Research, Development & Clinical Design for the company. Dr. Tari Ashizawa is a leading expert in liposomes, and was instrumental in the development of Bio-Path’s neutral lipid delivery technology. She was previously an associate professor at the University of Texas M.D. Anderson Cancer Center and the University of Florida, Gainesville. Dr. Tari Ashizawa holds a doctorate in biochemistry from the University of Tennessee, and a Master of Business Administration from the University of Florida.